The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.
 
Yan Sun
No Relationships to Disclose
 
Chaosu Hu
No Relationships to Disclose
 
Qin Lin
No Relationships to Disclose
 
Li Gao
No Relationships to Disclose
 
Jianhua Wang
No Relationships to Disclose
 
Xiaodong Zhu
No Relationships to Disclose
 
Junfang Hao
No Relationships to Disclose
 
Jin Yi Lang
No Relationships to Disclose
 
Peiguo Wang
No Relationships to Disclose
 
Ming Ye
No Relationships to Disclose
 
Xia Li
No Relationships to Disclose
 
Benhua Xu
No Relationships to Disclose
 
Rong Wu
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Qingshan You
No Relationships to Disclose
 
Xiaozhong Chen
No Relationships to Disclose
 
Jun Wang
No Relationships to Disclose
 
Desheng Hu
No Relationships to Disclose
 
Gang Wu
No Relationships to Disclose
 
Jian-ji Pan
No Relationships to Disclose